The SIBERIA Trial (Acculink™ Versus CGuard™)

Clinical trial NCT03488199 · COMPLETED

Trial details

NCT number: NCT03488199
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Patients With Aterosclerotic Carotid Stenosis Symptomatic Patients (Stenosis > 50%)Asymptomatic Patients (Stenosis ≥80%)

Start date: 2017-09-11
Primary completion: 2021-02-11
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.